GSK Statistics
Total Valuation
GSK plc has a market cap or net worth of $82.86 billion. The enterprise value is $98.56 billion.
| Market Cap | 82.86B |
| Enterprise Value | 98.56B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | Feb 22, 2024 |
Share Statistics
GSK plc has 2.03 billion shares outstanding.
| Shares Outstanding | 2.03B |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 14.85% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 13.89 and the forward PE ratio is 10.32. GSK plc's PEG ratio is 1.09.
| PE Ratio | 13.89 |
| Forward PE | 10.32 |
| PS Ratio | 2.15 |
| Forward PS | 2.57 |
| PB Ratio | 4.98 |
| P/FCF Ratio | 12.12 |
| PEG Ratio | 1.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.24, with an EV/FCF ratio of 14.46.
| EV / Earnings | 15.80 |
| EV / Sales | 2.57 |
| EV / EBITDA | 12.24 |
| EV / EBIT | 12.24 |
| EV / FCF | 14.46 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 1.35.
| Current Ratio | 0.89 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | 2.78 |
| Debt / FCF | 3.29 |
| Interest Coverage | 8.18 |
Financial Efficiency
Return on equity (ROE) is 38.70% and return on invested capital (ROIC) is 18.64%.
| Return on Equity (ROE) | 38.70% |
| Return on Assets (ROA) | 8.30% |
| Return on Capital (ROIC) | 18.64% |
| Revenue Per Employee | $546,771 |
| Profits Per Employee | $88,845 |
| Employee Count | 70,212 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.61 |
Taxes
In the past 12 months, GSK plc has paid $939.90 million in taxes.
| Income Tax | 939.90M |
| Effective Tax Rate | 13.09% |
Stock Price Statistics
The stock price has increased by +11.47% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
| Beta (1Y) | 0.27 |
| 52-Week Price Change | +11.47% |
| 50-Day Moving Average | 41.83 |
| 200-Day Moving Average | 37.88 |
| Relative Strength Index (RSI) | 47.93 |
| Average Volume (30 Days) | 3,518,780 |
Short Selling Information
| Short Interest | 4.83M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 0.72% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.83 |
Income Statement
In the last 12 months, GSK plc had revenue of $38.39 billion and earned $6.24 billion in profits. Earnings per share was $2.98.
| Revenue | 38.39B |
| Gross Profit | 27.06B |
| Operating Income | 8.39B |
| Pretax Income | 7.07B |
| Net Income | 6.24B |
| EBITDA | 8.05B |
| EBIT | 8.05B |
| Earnings Per Share (EPS) | $2.98 |
Balance Sheet
The company has $6.44 billion in cash and $22.40 billion in debt, giving a net cash position of -$15.96 billion or -$7.86 per share.
| Cash & Cash Equivalents | 6.44B |
| Total Debt | 22.40B |
| Net Cash | -15.96B |
| Net Cash Per Share | -$7.86 |
| Equity / Book Value | 16.59B |
| Book Value Per Share | 8.18 |
| Working Capital | -3.01B |
Cash Flow
In the last 12 months, operating cash flow was $8.41 billion and capital expenditures -$1.60 billion, giving a free cash flow of $6.82 billion.
| Operating Cash Flow | 8.41B |
| Capital Expenditures | -1.60B |
| Free Cash Flow | 6.82B |
| FCF Per Share | $3.36 |
Margins
Gross margin is 70.48%, with operating and profit margins of 21.84% and 16.25%.
| Gross Margin | 70.48% |
| Operating Margin | 21.84% |
| Pretax Margin | 18.41% |
| Profit Margin | 16.25% |
| EBITDA Margin | 20.97% |
| EBIT Margin | 20.97% |
| FCF Margin | 17.75% |
Dividends & Yields
This stock pays an annual dividend of $1.62, which amounts to a dividend yield of 3.97%.
| Dividend Per Share | $1.62 |
| Dividend Yield | 3.97% |
| Dividend Growth (YoY) | 5.36% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.68% |
| Buyback Yield | -0.62% |
| Shareholder Yield | 3.36% |
| Earnings Yield | 7.55% |
| FCF Yield | 8.25% |
Analyst Forecast
The average price target for GSK plc is $46.00, which is 12.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $46.00 |
| Price Target Difference | 12.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 4.45% |
| EPS Growth Forecast (5Y) | -4.75% |
Stock Splits
The last stock split was on July 22, 2022. It was a forward split with a ratio of 1226:1000.
| Last Split Date | Jul 22, 2022 |
| Split Type | Forward |
| Split Ratio | 1226:1000 |
Scores
GSK plc has an Altman Z-Score of 1.87 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.87 |
| Piotroski F-Score | 7 |